@article{2951556,
    title = "Prospective, open-label, randomized, phase III study of two dose-dense regimens MVAC versus gemcitabine/cisplatin in patients with inoperable, metastatic or relapsed urothelial cancer: a Hellenic Cooperative Oncology Group study (HE 16/03)",
    author = "Bamias, A and Dafni, U and Karadimou, A and Timotheadou, E and Aravantinos, G and Psyrri, A and Xanthakis, I and Tsiatas, M and Koutoulidis, V and Constantinidis, C and others",
    journal = "Annals of Oncology",
    year = "2013",
    volume = "24",
    number = "4",
    pages = "1011--1017",
    publisher = "Elsevier",
    issn = "0923-7534, 1569-8041"
}